Stress Testing Webinar Series: Enterprise-wide Stress Testing
Stress testing 2013
-
Upload
tommarkermd -
Category
Documents
-
view
368 -
download
0
Transcript of Stress testing 2013
Tom Marker MD FACC
Cardiovascular Consultants of Oregon
Questions on Stress Testing What are the indications for a treadmill test (what
type of patient should we consider)?How do Beta –blockers effect stress testing?
Should they be discontinued before testing?How long does the patient need to be NPO prior to
test?What contraindications exist for treadmill testing?
What about LBBB (or RBBB)?How is understanding of Bayesian statistical theory
important when ordering stress tests?
NPO and Stress TestingFor ETT, overnight fast or 2 hours post prandialFor MPI (myocardial perfusion imaging) want > 4
hours NPO for both resting and stress imaging
PURPOSES OF CARDIAC STRESS TESTINGTo aid in establishing the diagnosis of CAD and
assess suspected or proven CADTo estimate prognosis (risk stratification)As a tool to determine functional capacity or the
effects of therapyResults can be enhanced by combining with
Metabolic Gas Analysis, Radionuclide Imaging, Echocardiography
I. Diagnosis of Obstructive Coronary Artery Disease
II. Risk Assessment and Prognosis in Patients with Symptoms or a Prior History of Coronary Artery Disease
III. Post MI Risk Assessment and Prognosis
IV. Special GroupsAsymptomatic PatientsPost Revascularization PatientsRhythm DisordersWomen
Indications for Non-Invasive Cardiac Stress Testing
• Class I: Conditions for which there is evidence and/or general agreement that a given procedure or treatment is useful and effective
• Class II: Conditions for which there is conflicting evidence and /or a divergence of opinion about the usefulness/efficacy of a procedure or treatment.
IIA Weight of evidence/opinion is in favor of usefulness/efficacy
IIB Usefulness/efficacy is less well established by evidence/opinion
• Class III: Conditions for which there is evidence and/or general agreement that the procedure/treatment is not useful/effective and in some cases may be harmful.
I. Diagnosis of Obstructive Coronary Artery Disease Using ETT
• Class I: Adult patients with an intermediate pretest probability of CAD. Includes RBBB or less than 1 mm of resting ST depression
• Class II A: Patients with vasospastic angina
• Class II B: High pretest likelihood of CAD
Low pretest likelihood of CAD
Patients taking digoxin
Patients with LVH on EKG
• Class III: WPW, Paced, LBBB, >1mm ST depression at rest
ACC/AHA 2002 Guideline Update for Exercise Testing
Age (Yr)
Gender Typical Angina
Atypical Angina
Non-Anginal
Asymptomatic
30-39 Men Intermediate Intermediate Low Very Low
Women Intermediate Very Low Very Low Very Low
40-49 Men High Intermediate Intermediate Low
Women Intermediate Low Very Low Very Low
50-59 Men High Intermediate Intermediate Low
Women Intermediate Intermediate Low Very Low
60-69 Men High Intermediate Intermediate Low
Women High Intermediate Intermediate Low
Pretest Probability of Obstructive CAD
Diagnostic Utility Greatest in the Intermediate Pretest Probability Group
Diagnosis of Obstructive Coronary Artery Disease
High > 90% Intermediate-> 10-90% Low 5-10% Very Low <5%
Circulation 64, no. 2, 1981
Typical Angina
Patients with substernal discomfort precipitated by exertion and relieved by rest or NTG lasting 5 to 10 minutes; often radiating to jaw, neck, shoulder or inner aspect of the arm.
Probable Angina
Patients described most of the features of typical angina but were atypical in some respects, e.g.; atypical radiation, non-exertional, NTG ineffective, prolonged for more than 15-20 minutes after rest if exertional.
Non-anginal chest pain
Patients with overall pattern of chest pain different from above, e.g., different character of discomfort (sharp), nonexertional or unrelieved by rest, unrelieved by NTG, or otherwise apparently non-cardiac in origin.
The Importance of Bayesian Theory on Noninvasive Testing for CAD
PV = % of pts with abnormal test who have CAD TP/TP + FP
ETT Sensitivity and SpecificitySensitivity = 68%Specificity = 77%Predictive Accuracy = 73%Based on Meta Analysis of 147 studies including
24,047 subjects
Predictive Accuracy = % of true test results TP +TN/total # tests performed
STRESS TESTING FOR THE DIAGNOSIS OF CAD
Ischemia Induction (or demonstration of differences in perfusion)
Exercise
Pharmacological
Adenosine (with or without exercise)
Dipyridamole (with or without exercise)
Dobutamine (with or without Atropine)
Ischemia Detection (or ‘differences in perfusion’ detection)
Surrogate for Ischemia
EKG (ETT) ST Segment Changes
Echocardiography Regional Wall Motion Changes
(Stress Echo)
SPECT MPI Regional Photon Count Changes
Cardiac Stress Testing in the Adult
Advantages of the Standard Exercise EKG Stress Test
Low Cost, Availability, Acceptability, Convenience
Exercise tolerance determined
Provides independent prognostic information
Correlate symptoms with activity
Assess rhythm, rate, BP, response to activity
Disadvantages of the Standard Exercise EKG Stress Test
Limited Sensitivity and Specificity
Does not localize ischemia
No Estimate of LV Function
Requires Cooperation and Ability to Walk
Benefits of Pharmacological Stress Testing with Imaging over Exercise Stress (+/- Imaging)
• Can be applied to almost all patients
• Less motion artifact (Ex. Echo)
• % of Patients not able to reach adequate HR may approach 40% - provides an alternative with comparable sensitivity/specificity
Cardiac Stress Testing in the Adult
ETT: Myocardial Physiology
Myocardial oxgen consumption is affected by: HR, SBP, LVEDV, Wall Thickness, Contratility
RPP = HR x SBP => Estimates MO2With normal individual’s Myocardial O2 Supply is
determined by demand and is sufficient (Coronaries, Valves, Myocardium, Hgb, etc all normal)
Myocardium is Aerobic (little capacity for anaerobic fx) AND Myocardial O2 extraction is at near-Max at rest: therefore to increase MO2 must increase coronary blood flow
There is a direct linear relationship between MO2 and Coronary Blood Flow
In obstructive CAD demand can exceed ability to supply and ischemic threshold can be crossed
Normal response to progressive treadmill protocol in healthy subjects. bpm Indicates beats per minute.
Fletcher G F et al. Circulation 1995;91:580-615
Copyright © American Heart Association
Cardiac Stress Testing in the AdultAssessment of Maximal Effort
Borg scale 17-20
Signs of fatigue, profound dyspnea
Age-predicted maximal heart rate (MPHR = 220-age)
Age-predicted MET level attained (Max MET = 18.0 - 0.15(age)
Example
60 YO patient
MPHR = (220-60) = 160
Max MET = 18.0 - (.15x60)
= 18.0-9.0 = 9.0* Morris CK, Myers J. Kawaguchi, T, et al: Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men. J Am coll Cardiol 1993; 22: 175-182
Borg Scale for Rating Perceived Exertion
Decreased Myocardial Perfusion resulting in the onset
of Ischemia
Regional Wall Motion
Changes
ST Segment Changes
Development of Angina
Start Exercise
Timeline of Events During Exercise Stress
Time
Timeline not to scale
The Ischemic Cascade
EKG Exercise Testing
Positive: Classical Definition
A. ST Segment Depression > 0.1x mV 80mSec after the J Point
B. Horizontal ST Segment Depression > 0.1 mV
C. Downsloping ST Segment Depression
Normal Abnormal
A B C
SlowUpslope
Horizontal DownSloping
AHA/ACC 2013 Exercise Standards for Stress Testing
Cardiac Stress Testing in the Adult
Exercise Test Termination
Absolute Reasons
Drop in Systolic BP > 10 mm Hg when accompanied by other evidence of ischemia
Moderate to severe angina
Increasing nervous system symptoms(e.g. ataxia, dizziness)
Signs of poor perfusion (pallor, cyanosis)
Subject’s desire to stop
Sustained VT
ST elevation > 1 mm in leads without diagnostic Q waves (other than V1 or aVR)
ACC/AHA 2002 Guideline Update for Exercise Testing
Cardiac Stress Testing in the Adult
Exercise Test Termination
Relative Reasons
Drop in systolic BP > 10 in the absence of other symptoms of ischemia
ST or QRS changes such as excessive ST depression (> 2 mm) or marked axis shift
Arrhythmias other than sustained VT
Fatigue, dyspnea, wheezing, leg cramps, claudication
Development of BBB or an IVCD that cannot be distinguished from VT
Increasing chest pain
Hypertensive response to exercise (>250/115)
ACC/AHA 2002 Guideline Update for Exercise Testing
EXERCISE PARAMETERS ASSOCIATED WITH A POOR PROGNOSIS AND INCREASE LIKELIHOOD OF
MULTIVESSEL CADDuration of symptom-limited exercise < 6 METsFailure to increase SBP > 12o mmHg; or sustained
decrease SBP of over 10 mmHg.ST segment depression > 2 mm; downsloping ST
depression starting at < 6 METs, involving > 5 leads, lasting over 5 minutes in recovery
ST segment elevation in a lead without Q waves (and not aVr or V1)
Angina during exerciseReproducible sustained (>30 sec) or symptomatic VT
Data Demonstrating Prognostic Value of ETT
Copyright ©1997 American Heart Association
Gibbons, R. J. et al. Circulation 1997;96:345-354
Nomogram of the prognostic relations embodied in the treadmill score
DUKE TREADMILL SCORE
MEASUREMENTS AVAILABLE FROM ETT EKG
Maximum ST depression or elevation ST depression slope (downsloping, horizontal, upsloping) Number of leads with ST depression Duration of ST changes into recovery ST/HR indexes Exercise –induced ventricular arrhythmias Time to onset of ST deviation
HEMODYNAMIC Maximum exercise HR and SBP Maximum Double Product (HRxSBP) Total exercise duration/METS achieved Exertional hypotension (lower than baseline pre-exercise BP) Chronotropic incompetence
SYMPTOMATIC Exercise induced Angina Pectoris Exercise limiting symptoms Time to onset of Angina Pectoris
SAFETY AND RISKS OF EXERCISE TESTING
Nonselected patient population: Mortality < 0.01% and Morbidity < 0.05%
Within 4 weeks of MI: Mortality = 0.03% and Morbidity = 0.09% (reinfarction, cardiac arrest)
Cardiac Stress Testing in the Adult
Absolute
Acute MI
High Risk UA
Uncontrolled Arrhythmias causing symptoms or hemodynamic compromise
Uncontrolled Heart Failure
Symptomatic Severe Aortic Stenosis
Acute Pulmonary Embolism or Pulmonary Infarction
Acute Pericarditis / Myocarditis
Acute Aortic Dissection
Relative
Left Main Stenosis
Moderate Aortic or Mitral Stenosis
Electrolyte abnormalities
Severe Hypertension(>200/110)
IHSS
Mental or Physical Impairment leading to inability to exercise
High Grade AV Block
Tachycardias or Bradyarrhythmias
Mental or Physical impairment that limits adequate levels of exercise
Contraindications to Exercise Stress
Cardiac Stress Testing in the Adult
Contraindications to Pharmacologic Stress
ACTIVE ASTHMA -- ADENOSINE/DIPYRIDAMOLE
HIGH GRADE AV BLOCK -- ADENOSINE
First Degree or Wenchebach AV Block -- Adenosine
Mild Bronchospastic disease – Adenosine/Dipyridamole
Absolute
Acute MI
High Risk UA
Uncontrolled Arrhythmias causing symptoms or hemodynamic compromise
Uncontrolled Heart Failure
Symptomatic Severe Aortic Stenosis
Acute Pulmonary Embolism or Pulmonary Infarction
Acute Pericarditis / Myocarditis
Acute Aortic Dissection
Relative
Left Main Stenosis
Moderate Aortic or Mitral Stenosis
Electrolyte abnormalities
Severe Hypertension(>200/110)
IHSS
Mental or Physical Impairment leading to inability to exercise
High Grade AV Block
Tachycardias or Bradyarrhythmias
Mental or Physical impairment that limits adequate levels of exercise
Beta BlockersReduce mortality and reinfarction after MIReduce frequency of angina and increase the anginal
thresholdSlow HR, reduce MVO2, prolong diastole and
perfusion time, reduce RPPReduce the sensitivity of Stress testing for the
diagnosis of CAD (Exercise as well as Pharmacologic stress tests)
BETA BLOCKER THERAPY AND ETT
In general, when doing ETT for the purpose of (new) diagnosis of CAD, try to withdraw Beta Blocker therapy prior to test
In general, when trying to assess the effectiveness of medical therapy for CAD or symptoms in a patient with known CAD on Beta Blocker therapy, best to continue their use prior to the test
Comparative Sensitivity, Specificity, and Accuracy of EKG and Imaging Stress Tests
Test Sensitivity Specificity Accuracy
ETT 68% 77% 73%
MPI 87% 78% 82%
SEcho 88% 80% 84%
Costs of Exercise Stress Tests at GSRMC
Cardiac Test Total Cost at GSRMC
CXR, 2V $299.00
EKG $45.00
ETT $489.00
COMPLETE ECHO $1,128.00
STRESS ECHO, ETT $1,350.00
STRESS ECHO, DOBUT $1,550.00
MPI STRESS, ETT $2,000.00
MPI STRESS, ADENOSINE $2,797.00
MPI STRESS, DOBUT $2,446.00
STRESS ECHOCARDIOGRAPHY
2D Echo imaging before, during and after cardiovascular stress
Cost effective means to assess CPStress ETT, Bicycle ergometer, DobutCompare wall motion at rest to stress can identify
inducible ischemic dysfx and assign a specific coronary territory
Sensitivity~88% (74-97): Specificity~84% (62-93%)
Stress Echocardiography
Advantages
Comprehensive – Ischemia, EF, Valvular function
Widely available
Relatively low cost
Disadvantages
Limited by echocardiographic windows and body habitus
Highly technician dependent
Steep technician learning curve
Interpreting physician dependent
FACTORS AFFECTING STRESS ECHOCARDIOGRAPHY
False Negatives False PositivesInadequate stressAntianginal therapyLeft Circumflex diseasePoor image qualityDelayed image acquisition
Interpreter bias (“over-call”)Basal Inferior Wall locationAbnormal septal motion due
to LBBB, Paced Rhythm, post CABG
CardiomyopathyHypertensive response to
stress
Nuclear Cardiology: SPECT Perfusion
Injected isotope extracted by viable myocytesPhotons emitted from myocardium in proportion to
uptake, which is related to perfusionGamma camera captures gamma photons and converts to
digital data representing magnitude and location of uptakePhotons Collimator Detector crystal Scintillation
events photo multiplier Processing computerSingle Photon Emission Computed Tomography SPECT
images: Myocardial perfusion images (MPI) represent distribution of perfusion throughout myocardium
Advantages
Applicable to almost all patients
Incremental value - prognosis, guidance to therapy
Assessment of LV function
Disadvantages
Detects coronary heterogeneity as a surrogate for ischemia
Relatively Expensive
Artifacts
Isotope availability
Radiation exposure
Cardiac Scinitgraphy Techniques
CAPTURE OF EMITED PHOTONS BY A GAMMA CAMERA
SPECT IMAGING TECHNIQUE
SPECT TOMOGRAPHIC DISPLAY SHORT AXIS
SPECT TOMOGRAPHIC DISPLAY VERTICAL LONG AXIS
SPECT TOMOGRAPHIC DISPLAY HORIZONTAL LONG AXIS
EFFECT OF CORONARY RESISTANCE ON CORONARY BLOOD FLOW RESERVE 1
EFFECT OF CORONARY RESISTANCE ON CORONARY BLOOD FLOW RESERVE 2
CORONARY BLOOD FLOW RESERVE ABNORMALITIES
MPI SPECT REVERSIBLE DEFECTS: ANTETERIOR AND APICAL
MPI STRESS TEST REPORTS INormalFixed defect implies Myocardial InfarctionReversible defect implies obstructive CAD/ischemiaMixed defect implies “partial thickness infarct” with
ischemia in remaining, viable myocardium
MPI STRESS TEST REPORT II
17 Segment Cardiac modelScored 0 – 4 (0 is normal, 4 is severely abnormal);
total = 68 (4x17)SSS (sum stress score) SRS (sum rest score) SDS (sum
difference score): Normal – 0 - 3 Mild – 4-8 Moderate – 8-12 Severe – 13 or greater
Total Perfusion Defect (TPD) - % myocardium estimated involved (SSS/68)
Severity predicts prognosis/risk of MACE
PET IMAGING
II. Risk Assessment and Prognosis in Patients with Symptoms or a Prior History of Coronary Artery Disease
• Class I: Patients undergoing initial evaluation with suspected CAD (Specific exceptions noted in II B below)
Patients with suspected or known CAD previously evaluated with significant change in clinical status
Low risk unstable angina patients 8 hrs post presentation free of active ischemia or CHF
Intermediate risk UA patients 2 days post presentation free of active ischemia or CHF
• Class II A: Intermediate risk UA with negative markers and EKGs 6 hrs post symptoms
• Class II B: Patients with resting EKG abnormalities including
Pre-excitation
Paced Rhythm
Greater than 1 mm resting ST depression
Complete LBBB
• Class III: Patients with severe comorbidity likely to limit life expectacy and/or candidacy for revascularization
ACC/AHA 2002 Guideline Update for Exercise Testing
III. Post MI Risk Assessment and Prognosis
Class I
Before discharge for prognostic assessment, activity prescription, evaluation of medical therapy (submaximal at about 4 to 6 days.
Early after discharge for prognostic assessment, activity prescription, evaluation of medical therapy, and cardiac rehabilitation if the predischarge exercise test was not done (symptom limited; about 14 to 21 days).
Late after discharge for prognostic assessment, activity prescription, evaluation of medical therapy, and cardiac rehabilitation if the early exercise test was submaximal(symptom limited; about 3 to 6 weeks
Class IIa
After discharge for activity counseling and/or exercise training as part of cardiac rehabilitation in patients who have undergone CABG
Class IIb
Patients with the following EKG abnormalities:
LBBB, Pre-excitation, LVH, Digoxin, >1mm ST depression, Ventricular paced rhythm
Periodic monitoring in patients who continue to participate in exercise training or cardiac rehabilitation
Class III
Severe comorbidity limiting life expectancy
ACC/AHA 2002 Guideline Update for Exercise Testing
IV. Exercise Testing Special Groups
A. Asymptomatic Patients without known CAD
• Class I: None• Class II A: Diabetics who plan to start vigorous exercise
• Class II B: Evaluation of patients with multiple risk factors
Evaluation of Asymptomatic men older than 40 years and women older than 50 years:
who plan to start exercise program
Who are involved in occupations in which impairment might impact public safety
Who are at high risk for CAD due to other diseases (e.g. chronic renal failure, diabetes mellitus)
• Class III: Routine Screening of asymptomatic men or women
ACC/AHA 2002 Guideline Update for Exercise Testing
IV. Exercise Testing Special Groups
B. Exercise Testing Before and After Revascularization
Class I: Demonstration of ischemia before revascularization
Evaluation of patients with recurrent symptoms suggesting ischemia after revascularization
Class II
A: After discharge for activity counseling and/or exercise training as part of cardiac rehab in patients who have undergone coronary revascularization
Class II
B: Detection of restenosis in selected, high-risk asymptomatic patients within the first months after angioplasty
Periodic monitoring of selected, high-risk asymptomatic patients for restenosis, graft occlusion, or disease progression
Class III: Localization of ischemia for determining the site of intervention (EKG stress testing only) Routine, periodic monitoring of asymptomatic patients after PTCA or CABG
Routine periodic monitoring following PCI or CABG without indications
ACC/AHA 2002 Guideline Update for Exercise Testing
IV. Exercise Testing Special Groups
C. Assessment of Rhythm Disorders
Class I:
Identification of appropriate settings in patients with rate-adaptive pacemakers
Evaluation of congenital CHB in patients considering increased physical activity or participation in competitive sports
Class II A:
Evaluation of patients with known or suspected exercise-induced arrhythmias
Evaluation of medical, surgical, or ablative therapy in patients with exercise induced arrythmias (including atrial fibrillation)
Class II B:
Investigation of isolated ventricular ectopic beats in middle-aged patients without other evidence of CAD
Investigation of prolonged 1st degree or 2nd degree AVB, LBBB, RBBB, or isolated VPC’s in young patients considering participation in competitive sports
Class III:
Investigation of isolated ectopic beats in young patients
ACC/AHA 2002 Guideline Update for Exercise Testing
IV. Exercise Testing Special Groups
D. Women
Exercise Testing in Women Less Sensitive than Men
Sensitivity = 61%
Lower Prevalence of Severe CAD (from Bayesian standpoint, this creates a difficult situation for noninvasive testing)
Higher incidence of Single Vessel CAD
Inability to exercise to maximum aerobic capacity
The ST response to exercise appears to be gender-related from an early age, with ST-segment abnormalities more common in third-grade girls than boys
Exercise Testing In Women Less Specific than Men
Specificity = 68%
Greater prevalence of:
Mitral Valve Prolapse
Syndrome X
Prognostic Factors for Patients with Coronary Disease
IV. Exercise Testing Special Groups
D. Women
“ Concerns about false-positive ST-segment responses may be addressed by careful assessment of post test probability and selective use of stress imaging tests before proceeding to angiography”
“The optimal strategy for circumventing false-positive test results for diagnosis of CAD in women remains to be defined”
ACC/AHA Guideline for Exercise Testing 1997
ACC/AHA Guideline for Exercise Testing 2002“Although the optimal strategy for circumventing false-positive test results for diagnosis of CAD in women remains to be defined, there are currently insufficient data to justify routine stress imaging tests as the initial test for CAD in women
A Negative Standard Maximal Exercise Test Gives Important Information Predicting Low Likelihood of Occlusive Coronary Artery Disease
A Positive Standard Maximal Exercise Test has lower Predictive Value than in men for the dx of Occlusive Coronary Artery Disease - Further Testing may be appropriate. Concern about false-positive ST-segment responses may be addressed by careful assessment of posttest probability and selective use of stress imaging tests before the patientproceeds to angiography.
IV. Exercise Testing Special Groups
D.Women
Vasodilators Inotropes Dipyridamole Adenosine Dobutamine Arbuamine
Side effect (n = 3911) (n = 9256) (n = 1118) (n = 697)
Total S/E 47% 81% 35% (cardiac) 51%Fatal MI 0.05% 0% 0 0Nonfatal MI 0.05% 0.01% 0 0.10%Bronchospasm 0.15% 0.07% 0 0Anxiety/tremor — — 6 % 14%Chest pain 20% 35 % 19 % 51 %Dizziness 12 % 9 % — 5 %Dyspnea 3 % 35 % 5 % 21 %Flushing 3 % 37 % — 6 %Headache 12 % 14 % 4 % 11 %Hypotension 5 % — 3 % 6 %
Cardiac Stress Testing in the AdultPharmacologic Stress Testing -- Side Effects
Factors That Affect Sensitivity and Specificity of Exercise or Pharmacologic Stress
Scintigraphy
False negatives False positivesDecreases Sensitivity Decreases Specificity
• Inadequate stress • Over interpretation, interpreter bias
• Antianginal therapy • Tissue Attenuation Artifacts• Mild CAD Breast, Diaphragm• Planar views only • LBBB• Balanced Ischemia (LM + RCA)
Author N = Imaging Modality Sensitivity Specificity
Quinones 1992 112 StressEcho 74 88
Tl SPECT 76 81
Pozzoli 1991 75 Stress Echo 71 96
MIBI SPECT 84 88
Salustri 1992 37 Stress Echo 83 86
MIBI SPECT 87 71
Direct Diagnostic Comparisons between Exercise Stress Echocardiography and Exercise Perfusion Scintigraphy
Author N = Imaging Modality Sensitivity Specificity
Gunalp 1993 19 Dobut Echo 70 89
MIBI SPECT 90 89
Marwick 1993 217 Dobut Echo 72 83
MIBI SPECT 76 67
Forster 1993 21 Dobut Echo 75 89
MIBI SPECT 83 89
Senior 1994 61 Dobut Echo 93 94
MIBI SPECT 95 71
Total 390 Function 80 91
Perfusion 81 71
Direct Diagnostic Comparisons between Dobutamine Stress Echocardiography and Dobutamine Stress Perfusion
Scintigraphy
Echocardiographic vs. Scinitigraphic Methods for the Detection of Occlusive
Coronary Artery Disease
SUMMARY
• Both techniques have comparable sensitivity and sensitivity
• Echocardiography is highly dependent on technician expertise
• Echocardiography is less costly
• Scintigraphy can be applied to almost all patients
The LBBB Problem
EKG: Insensitive due to resting ST repolarization changes
Echo: Resting wall motion changes due to paradoxical septal motion
SPECT MPI Septal asynchrony with decreased diastolic time interval (coronary filling time) results in relative septal hypoperfusion
Patients with resting LBBB, or those that develop rate related LBBB should undergo adenosine perfusion imaging without exercise.
The Future 64 Slice CT Scan
Non-Invasive Angiography
Sensitivity 94%
Specificity 97%
PPV 97%
NPV 93%
Am J Cardiol 2006; 98:145-148
Relative Costs of Exercise Stress Tests based on RVU Analysis
Test HCPCS Description RVU'sTotal Test
RVU'sMedicare
Cost
EKG Stress Test 93015 Cardiovascular stress test 2.85 2.85 $105.45
Stress Echocardiography 93015 Cardiovascular stress test 2.85 6.85 $253.4593350 Echo transthoracic 4
Stress MPI 93015 Cardiovascular stress test 2.85 22.37 $827.69
78465 Heart image (3d), multiple 14.4778478 Heart wall motion add-on 2.5378480 Heart function add-on 2.52
64 Slice CT Scan 71275 Ct angiography, chest 15.45 15.45 $571.65
Coronary Angiography 93545 Inject for coronary x-rays 46.17 54.53 $2,017.6193555 Imaging, cardiac cath 0.57 93510 Left heart catheterization 7.79
Exercise TestingSuggested Approach
Dx CAD Certain?
Risk Prognosis Uncertain ?
Assess Rx, Exercise, or disability?
Contraindications to Stress?
Can Patient Exercise
Is Resting EKG Suitable for detecting Ischemia?
Do EKG Stress Test
C/W High Risk CAD ?
Dx Certain?
Consider Angiography
Pharmacologic Imaging
LBBB ?
Consider Angiography/Revascularization
Consider imaging study or angiography
Y
Y
N
N
N
Y NN
Continue/Initiate/Modify Plan
N
Y
Y
Y
N
N
Continue/Initiate/Modify Plan
N Adenosine SPECT MPI with Exercise
Y
Adenosine SPECT MPI
Inappropriate Use of SPECT MPI
Evaluation of chest pain in patient with low pretest likelihood of CAD, EKG interpretable and able to exercise
Symptomatic acute chest pain with high pretest probability of CAD and EKG showing ST elevation
Asymptomatic patient with low CAD risk based on Framingham Risk Criteria
Asymptomatic or stable symptoms with previously normal MPI, high CAD risk and annual MPI study ****
Inappropriate Use of SPECT MPI JACC Oct 18, 2005
Asymptomatic or stable symptoms with previously normal MPI, high CAD risk and annual MPI study
Exercise Testing After Coronary Artery Bypass Graft Surgery
“Because of these considerations, together with the need to document the site of ischemia, stress imaging tests are more favored in this group, although there are insufficient data to justify recommending a particular frequency of testing.”
ACC/AHA 2002 Guidline Update for Exercise Testing
Inappropriate Use of SPECT MPI****
Inappropriate Use of SPECT MPI
Asymptomatic and prior calcium agatston score less than 100
Preoperative risk assessment in Low-Risk Non-Cardiac surgery (eye, superficial)
Preoperative risk assessment in Intermediate-Risk Non-Cardiac surgery in patients with exercise tolerance > 4 METS
Preoperative Evaluation for High Risk, Non-Cardiac Surgery in Asymptomatic patients up to one year**** post normal cath, noninvasive test, or previous revascularization
Following ACS with complications (e.g. shock) in patients who underwent thrombolytics
Asymptomatic Post Revascularizatrion prior to “routine” hospital discharge
Asymptomatice Post-Revascularization in patients that were symptomatic prior to revascularization and less than two years after PCI****